Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Off-Label Wish List: Industry Groups Want US FDA's Guidances To Do More

Executive Summary

Sponsors and payers question guidances' scope and potential audiences, and wonder if the agency couldn't just perform some retrospective audits of off-label communication to speed things up.

Advertisement

Related Content

Off-Label Discussion, But No Additions, For House User Fee Bill
Off-Label Promotion Decisions Likely Made Case-by-Case, US FDA Official Says
FDA's Document Dump: Guidance Release Skyrockets Ahead Of Trump's Arrival
Industry Communications With Payors: US FDA Okays Info On Investigational Drugs
Off-Label Communication: When Does It Align With Approved Labeling?
Keep Limits On Off-Label Promotion, Consumers And Patients Say
‘Who Is The Arbiter?’ US FDA Asks As It Mulls Loosening Off-Label Reins
Off-Label Communications: Industry, FDA Debate Role Of Peer Review
Off-Label Communication Principles From PhRMA, BIO Aim For Reg Changes
Rx Economic Information-Sharing Concept Getting Renewed Push

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

PS120121

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel